Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Latest Breaking News
In reply to the discussion: Vials labeled 'smallpox' found at vaccine research facility in Pennsylvania, CDC says [View all]BumRushDaShow
(173,157 posts)18. Yup
I remember the debate. I think most "known" sources were eliminated but obviously there are probably vials still scattered all around the world. There was a big hullaboo about 7 years ago when some was found in an old FDA lab at NIH - https://www.cdc.gov/media/releases/2014/s0708-NIH.html
CDC Media Statement on Newly Discovered Smallpox Specimens
Media Statement
For Immediate Release: Tuesday, July 8, 2014
Contact: Media Relations, Office of Communication
(404) 639-3286
On July 1, 2014, the National Institutes of Health (NIH) notified the appropriate regulatory agency, the Division of Select Agents and Toxins (DSAT) of the Centers for Disease Control and Prevention (CDC), that employees discovered vials labeled variola, commonly known as smallpox, in an unused portion of a storage room in a Food and Drug Administration (FDA) laboratory located on the NIH Bethesda campus.
The laboratory was among those transferred from NIH to FDA in 1972, along with the responsibility for regulating biologic products. The FDA has operated laboratories located on the NIH campus since that time. Scientists discovered the vials while preparing for the laboratorys move to the FDAs main campus.
The vials appear to date from the 1950s. Upon discovery, the vials were immediately secured in a CDC-registered select agent containment laboratory in Bethesda.
There is no evidence that any of the vials labeled variola has been breached, and onsite biosafety personnel have not identified any infectious exposure risk to lab workers or the public.
Late on July 7, the vials were transported safely and securely with the assistance of federal and local law enforcement agencies to CDCs high-containment facility in Atlanta. Overnight PCR testing done by CDC in the BSL-4 lab confirmed the presence of variola virus DNA. Additional testing of the variola samples is under way to determine if the material in the vials is viable (i.e., can grow in tissue culture). This testing could take up to 2 weeks. After completion of this testing, the samples will be destroyed.
By international agreement, there are two official World Health Organization (WHO)-designated repositories for smallpox: CDC in Atlanta, Georgia and the State Research Centre of Virology and Biotechnology (VECTOR) in Novosibirsk, Russia. The WHO oversees the inspection of these smallpox facilities and conducts periodic reviews to certify the repositories for safety and security.
CDC has notified WHO about the discovery, and WHO has been invited to participate in the investigation. If viable smallpox is present, WHO will be invited to witness the destruction of these smallpox materials, as has been the precedent for other cases where smallpox samples have been found outside of the two official repositories.
DSAT, in collaboration with the Federal Bureau of Investigation, is actively investigating the history of how these samples were originally prepared and subsequently stored in the FDA laboratory.
###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Media Statement
For Immediate Release: Tuesday, July 8, 2014
Contact: Media Relations, Office of Communication
(404) 639-3286
On July 1, 2014, the National Institutes of Health (NIH) notified the appropriate regulatory agency, the Division of Select Agents and Toxins (DSAT) of the Centers for Disease Control and Prevention (CDC), that employees discovered vials labeled variola, commonly known as smallpox, in an unused portion of a storage room in a Food and Drug Administration (FDA) laboratory located on the NIH Bethesda campus.
The laboratory was among those transferred from NIH to FDA in 1972, along with the responsibility for regulating biologic products. The FDA has operated laboratories located on the NIH campus since that time. Scientists discovered the vials while preparing for the laboratorys move to the FDAs main campus.
The vials appear to date from the 1950s. Upon discovery, the vials were immediately secured in a CDC-registered select agent containment laboratory in Bethesda.
There is no evidence that any of the vials labeled variola has been breached, and onsite biosafety personnel have not identified any infectious exposure risk to lab workers or the public.
Late on July 7, the vials were transported safely and securely with the assistance of federal and local law enforcement agencies to CDCs high-containment facility in Atlanta. Overnight PCR testing done by CDC in the BSL-4 lab confirmed the presence of variola virus DNA. Additional testing of the variola samples is under way to determine if the material in the vials is viable (i.e., can grow in tissue culture). This testing could take up to 2 weeks. After completion of this testing, the samples will be destroyed.
By international agreement, there are two official World Health Organization (WHO)-designated repositories for smallpox: CDC in Atlanta, Georgia and the State Research Centre of Virology and Biotechnology (VECTOR) in Novosibirsk, Russia. The WHO oversees the inspection of these smallpox facilities and conducts periodic reviews to certify the repositories for safety and security.
CDC has notified WHO about the discovery, and WHO has been invited to participate in the investigation. If viable smallpox is present, WHO will be invited to witness the destruction of these smallpox materials, as has been the precedent for other cases where smallpox samples have been found outside of the two official repositories.
DSAT, in collaboration with the Federal Bureau of Investigation, is actively investigating the history of how these samples were originally prepared and subsequently stored in the FDA laboratory.
###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
They found that when CBER was in the process of moving to White Oak in Silver Spring.
Edit history
Please sign in to view edit histories.
Recommendations
0 members have recommended this reply (displayed in chronological order):
27 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
RecommendedHighlight replies with 5 or more recommendations
Vials labeled 'smallpox' found at vaccine research facility in Pennsylvania, CDC says [View all]
BumRushDaShow
Nov 2021
OP
My smallpox vaccine scar has disappeared. It was a different kind of scar, though:
tblue37
Nov 2021
#25
My oldest son, born 1967, was vaxxed for smallpox. My daughter, born 1969, was not.
Arkansas Granny
Nov 2021
#9
When smallpox was eliminated, there was discussion of maintaining a small collection of samples
3Hotdogs
Nov 2021
#13
7 yrs ago was when Obama called for an end to all gain of function research in US
womanofthehills
Nov 2021
#21
The CDC Biorepository has approximately 6.6 million biological and environmental samples.
twodogsbarking
Nov 2021
#22